OCD Trial, Recruiting (NCT07135414)

OCD Trial, Recruiting NCT07135414 Sponsor: University Hospital, Ghent Condition: OCD

Printed from Voxsanity (voxsanity.com.au) — NCT07135414 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ocd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are between 18 and 65 years old
People who are currently hospitalised for Obsessive-Compulsive Disorder (OCD)
People who are taking part in a type of therapy called Exposure and Response Prevention Therapy
People with moderate to severe OCD symptoms, measured using a standard clinical scale called the Y-BOCS, with a score of 20 or higher

Who may not be able to join:

People who are currently experiencing thoughts of suicide or showing suicidal behaviour
People who have an active psychotic disorder (a condition that can cause a loss of touch with reality)
People who currently have an active substance use disorder (a problematic pattern of using alcohol or drugs)
People who have a Deep Brain Stimulation (DBS) device already implanted for OCD (a device surgically placed in the brain to help manage symptoms)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chris Baeken, PhD. MD. Psychiatry, UZ GENT

Phone: 00329 332 43 94

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07135414

Sponsor: University Hospital, Ghent

Phase: Not Applicable

Status: Recruiting

Condition: OCD

Trial contact: 00329 332 43 94

More information: https://clinicaltrials.gov/study/NCT07135414

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are between 18 and 65 years old
People who are currently hospitalised for Obsessive-Compulsive Disorder (OCD)
People who are taking part in a type of therapy called Exposure and Response Prevention Therapy
People with moderate to severe OCD symptoms, measured using a standard clinical scale called the Y-BOCS, with a score of 20 or higher

Who may not be able to join:

People who are currently experiencing thoughts of suicide or showing suicidal behaviour
People who have an active psychotic disorder (a condition that can cause a loss of touch with reality)
People who currently have an active substance use disorder (a problematic pattern of using alcohol or drugs)
People who have a Deep Brain Stimulation (DBS) device already implanted for OCD (a device surgically placed in the brain to help manage symptoms)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Ghent

Registry

ClinicalTrials.gov

Start date

25 May 2025

Est. completion

31 December 2029

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Self-Reported Severity of Adverse Effects [Safety]; Incidence of Any Self-Reported Adverse Effect [Safety]; Participant Retention Rate [Feasibility]

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov